Astrana Health (ASTH) Debt to Equity (2012 - 2026)

Astrana Health has disclosed Debt to Equity across 15 years of filings, most recently posting $1.26 for Q1 2026.

• Debt to Equity for Q1 2026 came in at $1.26, up 127.19% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.26 (up 127.19% YoY), and the FY2025 annual result was $1.33, up 119.79% from the prior year.
• Debt to Equity came in at $1.26 for Q1 2026 at Astrana Health, down from $1.33 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $1.35 in Q3 2025 to a low of $0.35 in Q3 2023.
• The 5-year median for Debt to Equity is $0.54 (2025), against an average of $0.63.
• Across the five-year window, Debt to Equity tumbled 43.29% in 2022 and soared 127.19% in 2026, its largest moves.
• Astrana Health's Debt to Equity stood at $0.37 in 2022, then climbed by 20.47% to $0.45 in 2023, then surged by 34.31% to $0.61 in 2024, then jumped by 119.79% to $1.33 in 2025, then decreased by 5.43% to $1.26 in 2026.
• The last three Debt to Equity figures came in at $1.26 (Q1 2026), $1.33 (Q4 2025), and $1.35 (Q3 2025), per Business Quant data.